Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Olaparib and paclitaxel for 2nd line gastric cancer therapy

Dr Yung-Jue Bang - Seoul National University, Seoul, South Korea
Olaparib and paclitaxel for 2nd line gastric cancer therapy ( Dr Yung-Jue Bang - Seoul National University, Seoul, South Korea )
10 Oct 2016

Innovative uses of kinase inhibitors in cancer

Dr Jordi Rodón - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Innovative uses of kinase inhibitors in cancer ( Dr Jordi Rodón - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
10 Oct 2016

Comment: Ribociclib for breast cancer

Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium
Comment: Ribociclib for breast cancer ( Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium )
10 Oct 2016

Treating CNS metastases from breast cancer with a peptide/paclitaxel conjugate

Prof Shou-Ching Tang - Augusta University Cancer Center, Augusta USA
Treating CNS metastases from breast cancer with a peptide/paclitaxel conjugate ( Prof Shou-Ching Tang - Augusta University Cancer Center, Augusta USA )
10 Oct 2016

Highlights of ESMO 2016

Dr Andrés Cervantes - ESMO 2016 Scientific Chair
Highlights of ESMO 2016 ( Dr Andrés Cervantes - ESMO 2016 Scientific Chair )
10 Oct 2016

Longer disease-free survival in phase III trial of sunitinib as adjuvant treatment for kidney cancer

Dr Alain Ravaud - Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
Longer disease-free survival in phase III trial of sunitinib as adjuvant treatment for kidney cancer ( Dr Alain Ravaud - Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France )
10 Oct 2016

What is the future of proton therapy in the UK and worldwide?

Mr John Pettingell - Proton Partners International, Cardiff, UK
What is the future of proton therapy in the UK and worldwide? ( Mr John Pettingell - Proton Partners International, Cardiff, UK )
10 Oct 2016

Custirsen shows no survival benefit in metastatic prostate cancer

Prof Karim Fizazi - Institut Gustave Roussy, Villejuif, France
Custirsen shows no survival benefit in metastatic prostate cancer ( Prof Karim Fizazi - Institut Gustave Roussy, Villejuif, France )
10 Oct 2016

Benefits of adjuvant chemo for soft tissue sarcoma patients

Dr Alessandro Gronchi - National Cancer Institute, Milan, Italy
Benefits of adjuvant chemo for soft tissue sarcoma patients ( Dr Alessandro Gronchi - National Cancer Institute, Milan, Italy )
10 Oct 2016

Significant survival gains for neoadjuvant chemotherapy for high risk soft tissue sarcoma

Dr Alessandro Gronchi - National Cancer Institute, Milan, Italy
Significant survival gains for neoadjuvant chemotherapy for high risk soft tissue sarcoma ( Dr Alessandro Gronchi - National Cancer Institute, Milan, Italy )
10 Oct 2016

Cabozantinib over sunitinib for metastatic renal cell carcinoma

Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA
Cabozantinib over sunitinib for metastatic renal cell carcinoma ( Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA )
10 Oct 2016

How can we improve the reliability and quality of cancer registries?

Dr Ana-Maria Forsea - Carol Davila University of Medicine and Pharmacy Bucharest, Bucharest, Romania
How can we improve the reliability and quality of cancer registries? ( Dr Ana-Maria Forsea - Carol Davila University of Medicine and Pharmacy Bucharest, Bucharest, Romania )
10 Oct 2016